SCHEMBL31358682

SCHEMBL31358682

O=C(O)c1cccc(-c2ccc(C=C3Cc4ccccc4C3=O)o2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.59
POLB P06746 9/20 0.56
ALDH1A1 P00352 6/20 0.56
L3MBTL1 Q9Y468 5/20 0.56
KDM4E B2RXH2 4/20 0.56
TDP1 Q9NUW8 3/20 0.56
GSK3A P49840 2/20 0.56
GSK3B P49841 2/20 0.56
PIK3CG P48736 2/20 0.55
MAPT P10636 5/20 0.54
HPGD P15428 2/20 0.54
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
CTDSP1 Q9GZU7 2/20 0.52
GFER P55789 1/20 0.52
BCL2L1 Q07817 1/20 0.48
APEX1 P27695 2/20 0.48
RECQL P46063 2/20 0.48
MCL1 Q07820 2/20 0.48
APAF1 O14727 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26168567 1.00 PIM1 (0.59) PIM1POLBALDH1A1L3MBTL1KDM4E
SCHEMBL31358730 0.88 POLB (0.57) POLBALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL31358823 0.88 PIK3CG (0.58) PIM1POLBALDH1A1KDM4ETDP1
SCHEMBL31358786 0.85 POLB (0.61) PIM1POLBALDH1A1KDM4EGSK3A
SCHEMBL31358692 0.83 ALDH1A1 (0.57) PIM1POLBALDH1A1KDM4ETDP1
SCHEMBL25420537 0.83 AKT1 (0.70) POLBALDH1A1KDM4EMAPTHPGD
SCHEMBL31358822 0.83 AKT1 (0.70) POLBALDH1A1KDM4EMAPTHPGD
SCHEMBL26168390 0.83 AKT1 (0.70) POLBALDH1A1KDM4EMAPTHPGD
SCHEMBL26168421 0.83 POLB (0.65) PIM1POLBALDH1A1L3MBTL1KDM4E
SCHEMBL31358669 0.82 PTPN5 (0.63) POLBALDH1A1L3MBTL1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250026741-A1 INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute 2025-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026741-A1 INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF PTPN18, PTPN7, PTPN1 PIM1 695/4885POLB 3743/4885ALDH1A1 3926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.